RICARDO GOMEZ-VASQUEZ.: Open Payments
NPI 1801053715 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,052 in 35 payments from 9 companies in 2025. Trend: 2023 $1,450 · 2024 $1,356 · 2025 $1,052
Food & beverage: $1,052
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $574 |
| Amgen Inc. | 7 | $200 |
| Novo Nordisk Inc | 3 | $57 |
| Lilly USA, LLC | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Exact Sciences Corporation | 2 | $41 |
| PFIZER INC. | 2 | $39 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Indivior Inc. | 1 | $17 |
Products named: AIRSUPRA, FARXIGA, BREZTRI, REPATHA, JARDIANCE, OTEZLA, Ozempic, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
